Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

p53 gene analysis of ovarian borderline tumors and stage I carcinomas.

Human pathology - 1 Apr 1995

Kupryjanczyk J, Bell D A, Dimeo D, Beauchamp R, Thor A D, Yandell D W

Abstract excerpt

Mutations of the p53 gene are common in human ovarian carcinomas; however, their role in the early development of ovarian cancer is unclear. Twelve ovarian borderline tumors (BTs; eight of them p53 immunopositive) and 10 stage I carcinomas (four of them p53 immunopositive) were studied for genetic alterations in the p53 gene. The study was based on single-strand conformation polymorphism (SSCP) analysis and DNA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Genes, p53
Share to Immunohistochemistry

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Neoplasm Staging

Share to Ovarian Neoplasms

Share to Polymorphism, Single-Stranded Conformational

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 7705816
DOI: 10.1016/0046-8177(95)90138-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

p53 gene analysis of ovarian borderline tumors and stage I carcinomas.PMID 7705816Read ↗

TP53 protein accumulation and gene mutation in relation to overexpression of MDM2 protein in ovarian borderline tumours and stage I carcinomas.Semantic proximity Read ↗

p53 gene mutation in human borderline epithelial ovarian tumors.Semantic proximity Read ↗

Comparison of mutations of Ki-RAS and p53 immunoreactivity in borderline and malignant epithelial ovarian tumors.Semantic proximity Read ↗

Genetic alterations in ovarian borderline tumours and ovarian carcinomas.Semantic proximity Read ↗

Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation.Semantic proximity Read ↗

Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors.Semantic proximity Read ↗

k-ras mutation may be an early event in mucinous ovarian tumorigenesis.Semantic proximity Read ↗

Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy.Semantic proximity Read ↗

Allelic imbalance on chromosome 17p13 in borderline (low malignant potential) epithelial ovarian tumors.Semantic proximity Read ↗

Expression of cell regulatory proteins in ovarian borderline tumors.Semantic proximity Read ↗

Evaluation of a polymorphism in intron 2 of the p53 gene in ovarian cancer patients. From the Danish "Malova" Ovarian Cancer Study.Semantic proximity Read ↗

p53 mutation in epithelial ovarian carcinoma and borderline ovarian tumor.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.